Ameriprise Financial, Inc. filings document financial results, governance, executive and board matters, and shareholder voting for a Delaware financial services company with NYSE-listed common stock. Form 8-K disclosures include quarterly earnings releases, dividend actions, annual meeting results, director appointments, officer transitions and other material corporate events.
The company’s proxy materials cover director elections, board committee matters, executive compensation, equity awards, shareholder voting mechanics and related governance disclosures. Together, the filings describe Ameriprise’s public-company reporting around advice and wealth management, asset management, retirement and protection services, capital returns and oversight practices.
Ameriprise Financial (AMP): Director Christopher J. Williams reported a Form 4 transaction dated 11/04/2025. He acquired 45.6305 phantom stock units (retainer deferral), each representing the right to receive one share of Ameriprise common stock, under the company’s Deferred Share Plan for Directors.
Following the transaction, he beneficially owned 3,766.2747 derivative securities, held directly.
Ameriprise Financial (AMP) director reported a routine insider transaction. On 11/04/2025, the reporting person acquired 69.1371 phantom stock units under a retainer deferral program. Each phantom stock unit represents the right to receive one share of Ameriprise common stock.
Following this transaction, derivative securities beneficially owned totaled 218.9429, held directly. The filing lists a price of derivative security of $452. Distributions are made per participant elections under the Ameriprise Financial Deferred Share Plan for Directors.
Ameriprise Financial (AMP): Schedule 13G/A filing reports that JPMorgan Chase & Co. beneficially owns 3,866,962 shares of Ameriprise common stock, representing 4.1% of the class as of 10/31/2025.
JPMorgan reports sole voting power over 3,429,484 shares and shared voting power over 25,774 shares. It has sole dispositive power over 3,861,045 shares and shared dispositive power over 5,887 shares. The filing is made on Schedule 13G/A, indicating the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
Ameriprise Financial, Inc. reported much stronger results for the quarter ended September 30, 2025. Total revenues rose to $4,893 million from $4,560 million, while net income jumped to $912 million from $511 million. Diluted earnings per share increased to $9.33 from $5.00.
For the first nine months of 2025, net income grew to $2,555 million versus $2,330 million a year earlier. The balance sheet showed total assets of $190,086 million and total equity of $6,455 million. Operating cash flow was solid at $5,654 million, supporting dividends and significant share repurchases.
Ameriprise Financial (AMP) filed a Form 8-K to furnish a press release announcing its financial results for the third quarter of 2025. The release is provided as Exhibit 99.1 and is dated October 30, 2025. The disclosure is made under Item 2.02: Results of Operations and Financial Condition, with Exhibit 104 referencing the cover page Inline XBRL data.
JPMorgan Chase & Co. filed a Schedule 13G/A reporting beneficial ownership of 4,780,612 shares of Ameriprise Financial, Inc. common stock, representing 5.0% of the class as of 09/30/2025.
The filing lists 4,306,145 shares with sole voting power and 36,484 with shared voting power. It also reports 4,774,295 shares with sole dispositive power and 6,300 with shared dispositive power. JPMorgan certifies the holdings were acquired and are held in the ordinary course and not to change or influence control.
Ameriprise Financial insider sale reported. Heather J. Melloh, EVP and General Counsel of Ameriprise Financial (AMP), reported a sale of 1,500 shares of the company's common stock at a price of $512.335 per share. After the transaction the reporting person beneficially owned 2,562 shares. The Form 4 discloses the change in ownership for this officer but contains no additional commentary or derivative transactions.
Ameriprise Financial, Inc. (AMP) Form 144 notifies the market of a proposed sale of 1,500 shares of Common Stock on 09/04/2025 on the NYSE. The filing reports an aggregate market value of $768,502.50 for the shares and states there are 94,271,565 shares outstanding. The shares were acquired on 09/04/2025 through the vesting of compensatory equity awards from Ameriprise Financial, Inc., with payment characterized as Compensatory Equity Awards. The filer reports no securities sold by the same person in the past three months and affirms they are not aware of undisclosed material adverse information.
William F. Truscott, an officer of Ameriprise Financial, Inc. (AMP), reported multiple transactions in the company on August 19, 2025. He exercised employee stock options to acquire 28,546 shares at an exercise price of $165.41, resulting in 28,546 shares underlying the option and 28,546 common shares acquired. On the same day he sold 9,929 shares at a weighted average price of $506.8923 and sold an additional 18,617 shares at $506.57. The filing shows beneficial ownership balances after those transactions of 33,368 shares held directly, 11,047 shares held indirectly via an LLC, and an estimated 306.42 shares held in his Ameriprise 401(k) stock fund account. The reporting person certified the transactions and provided explanatory notes on tax-related forfeiture and 401(k) unit accounting.
Ameriprise Financial, Inc. (AMP) Form 144 shows a proposed sale of 9,929 shares of common stock valued at $5,032,933.59 to be sold on 08/19/2025 on the NYSE through American Enterprise Investment Services in Minneapolis. The filing reports the shares represent part of 94,271,565 shares outstanding and were acquired on 08/19/2025 via employee stock options from Ameriprise Financial, Inc., with the payment method noted as a Non-Qualified Stock Options Net Exercise. The filer indicates no securities sold in the past three months. The notice includes the standard representation that the seller has no undisclosed material adverse information.